Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment

Abstract

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

• Endometriosis: Diagnosis and Management via openalex
• Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care via openalex
• ‘Money for nothing’. The role of robotic-assisted laparoscopy for the treatment of endometriosis via openalex
• Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex
• Pelvic Endometriosis Diagnosed in an Entire Nation Over 20 Years via openalex
• Practice Bulletin No. 114: Management of Endometriosis via openalex
• Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex
• Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal via openalex
• Role of medical therapy in the management of deep rectovaginal endometriosis via openalex
• Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group via openalex
• The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
• Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex
• W125917936 via openalex
• W2735856415 via openalex
• W2613930366 via openalex
• W2132577372 via openalex
• W1998902846 via openalex
• W2163315477 via openalex

Cited by (12)

• Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
• Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? 2023
• Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
• Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
• Endometriosis - Recent Advances, New Perspectives and Treatments 2021
• Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
• When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement 2019
• National trends in inpatient endometriosis admissions: Patients, procedures and outcomes, 2006−2015 2019
• Endometrioma: a new paradigm of diagnostics and therapeutic tactics 2019
• Bowel surgery as a fertility-enhancing procedure in patients with colorectal endometriosis: methodological, pathogenic and ethical issues 2018
• Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? 2018
• Elagolix for endometriosis: all that glitters is not gold 2018

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:20:07.505861+00:00